Risk Factors
The incidence of oral mucositis varies across oncology patient populations and is related to individual patient factors as well as the type of therapy being received.
- Standard-dose chemotherapy – 40%
- Hematopoietic stem cell transplantation – 80%
- Radiation therapy for head and neck cancers - nearly 100%
From “Oral Mucositis”, (p. 334) by Brown, C.G., in C.G.Brown (Ed.), A guide to oncology symptom management, 2010, Pittsburgh, PA:Oncology Nursing Society. Reprinted with permission.
From “Oral Mucositis”, (p. 335) by Brown, C.G., in C.G.Brown (Ed.), A guide to oncology symptom management, 2010, Pittsburgh, PA: Oncology Nursing Society. Reprinted with permission.
From “Oral Mucositis”, (p. 336) by Brown, C.G., in C.G.Brown (Ed.), A guide to oncology symptom management, 2010, Pittsburgh, PA: Oncology Nursing Society. Reprinted with permission.